242 related articles for article (PubMed ID: 26463629)
1. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
[TBL] [Abstract][Full Text] [Related]
2. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.
Chen Y; Zhao R; Zhao Q; Shao Y; Zhang S
Oncol Res; 2016; 24(3):153-60. PubMed ID: 27458096
[TBL] [Abstract][Full Text] [Related]
4. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
5. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
[TBL] [Abstract][Full Text] [Related]
7. HPIP silencing inhibits TGF-β1-induced EMT in lung cancer cells.
Shi S; Zhao J; Wang J; Mi D; Ma Z
Int J Mol Med; 2017 Feb; 39(2):479-483. PubMed ID: 28075456
[TBL] [Abstract][Full Text] [Related]
8. HPIP Silencing Prevents Epithelial-Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells.
Zhang GY; Liu AH; Li GM; Wang JR
Oncol Res; 2016; 24(1):33-9. PubMed ID: 27178820
[TBL] [Abstract][Full Text] [Related]
9. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
Zhou Q; Chen J; Feng J; Xu Y; Zheng W; Wang J
Mol Cell Biochem; 2017 Nov; 435(1-2):87-95. PubMed ID: 28551845
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
Feng Y; Li L; Zhang X; Zhang Y; Liang Y; Lv J; Fan Z; Guo J; Hong T; Ji B; Ji Q; Mei G; Ding L; Zhang S; Xu X; Ye Q
Cancer Sci; 2015 Oct; 106(10):1313-22. PubMed ID: 26211905
[TBL] [Abstract][Full Text] [Related]
11. Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancer.
Khumukcham SS; Manavathi B
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188576. PubMed ID: 34090932
[TBL] [Abstract][Full Text] [Related]
12. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
13. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract][Full Text] [Related]
14. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
Ekpe-Adewuyi E; Lopez-Campistrous A; Tang X; Brindley DN; McMullen TP
Oncotarget; 2016 Dec; 7(50):83684-83700. PubMed ID: 27845909
[TBL] [Abstract][Full Text] [Related]
15. The involvement of hematopoietic pre-B cell leukemia transcription factor-interacting protein in regulating epithelial-mesenchymal transition of human spinal glioblastoma.
Wang D; Wang L; Zhou Y; Zhao X; Xiong H
Tumour Biol; 2016 May; 37(5):5897-903. PubMed ID: 26590606
[TBL] [Abstract][Full Text] [Related]
16. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
Liu Z; Chen M; Xie LK; Liu T; Zou ZW; Li Y; Chen P; Peng X; Ma C; Zhang WJ; Li PD
Aging (Albany NY); 2018 Oct; 10(10):2570-2584. PubMed ID: 30312171
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
Zheng L; Zhou Z; He Z
Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
[TBL] [Abstract][Full Text] [Related]
18. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
Miao X; Zhao Y
Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.
Nowicki TS; Zhao H; Darzynkiewicz Z; Moscatello A; Shin E; Schantz S; Tiwari RK; Geliebter J
Cell Cycle; 2011 Jan; 10(1):100-7. PubMed ID: 21191179
[TBL] [Abstract][Full Text] [Related]
20. HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway.
Pan J; Qin Y; Zhang M
Biomed Pharmacother; 2016 Feb; 77():176-81. PubMed ID: 26796282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]